Exhibit 99.1
Appendix 3Z
Final Director’s Interest Notice
Rule 3.19A.3
Appendix 3Z
Final Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
| Name of entity | Alterity Therapeutics Limited (ASX: ATH) |
| ABN | 37 080 699 065 |
We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of director | Dr. David Sinclair |
| Date of last notice | 21st September 2020 |
| Date that director ceased to be director | 4th January 2022 |
Part 1 – Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
7,000,000 options over ordinary shares issued under 2018 ADS ESOP Plan with exercise price of $0.09 each expiring 17/09/2025 have been forfeited upon resignation.
+ See chapter 19 for defined terms.
11/3/2002
Appendix 3Z
Final Director’s Interest Notice
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest Nil | Number & class of securities |
Part 3 – Director’s interests in contracts
| Detail of contract | N/A |
| Nature of interest | N/A |
| Name of registered holder (if issued securities) | N/A |
| No. and class of securities to which interest relates | N/A |
+ See chapter 19 for defined terms.
11/3/2002
Appendix 3Z
Final Director’s Interest Notice
Rule 3.19A.3
Appendix 3Z
Final Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
| Name of entity | Alterity Therapeutics Limited (ASX: ATH) |
| ABN | 37 080 699 065 |
We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of director | Tristan Edwards |
| Date of last notice | 21st September 2020 |
| Date that director ceased to be director | 4th January 2022 |
Part 1 – Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
7,000,000 options over ordinary shares issued under 2018 ADS ESOP Plan with exercise price of $0.09 each expiring 17/09/2025 have been forfeited upon resignation.
+ See chapter 19 for defined terms.
11/3/2002
Appendix 3Z
Final Director’s Interest Notice
Rule 3.19A.3
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest Nil | Number & class of securities |
Part 3 – Director’s interests in contracts
| Detail of contract | N/A |
| Nature of interest | N/A |
| Name of registered holder (if issued securities) | N/A |
| No. and class of securities to which interest relates | N/A |
+ See chapter 19 for defined terms.
11/3/2002
Appendix 3Z Page 2
